Skip to content
The 2025 BIO International Convention, hosted by the Biotechnology Innovation Organization (BIO), opens June 16 in Boston, bringing together over 20,000 industry leaders from […]
Welcome to BIO 2025: The world can’t wait. Read More »
The One Big Beautiful Bill Act – the “reconciliation bill” being considered by Congress – features policies that are crucial for driving American innovation.
America, for decades, has been the undisputed global leader when it comes to innovative drug development. But this leadership is now at risk. “We
BIO Coffee Chat: ORPHAN Cures Act key to fighting rare disease Read More »
Forty-five years ago, the Bayh-Dole Act enabled greater public-private partnership, supercharging U.S. innovation and helping make America a leader in biotech. The Bayh-Dole Coalition
Bayh-Dole Coalition promotes a law that supercharged innovation Read More »
In April 2025, the Department of Health and Human Services (HHS) announced it would disband the Advisory Committee on Heritable Disorders in Newborns and
Patient’s mother advocates for newborn screening program reform Read More »
Legislation introduced by Senators John Barrasso (R-WY) and Martin Heinrich (D-NM) would help protect the research and development of new treatments for patients with
Senators introduce bipartisan bill to protect new medicines for rare disease Read More »
A group led by the Biotechnology Innovation Organization (BIO) will recommend new international guidelines for manufacturers of cell and gene therapies (CGT) to support
BIO group to suggest global guidelines for regulating cell and gene therapies Read More »
May is Arthritis Awareness Month, and in observance, Bio.News asked AiArthritis to discuss how it is advancing the needs of patients with autoimmune and
Arthritis Awareness Month: AiArthritis puts a focus on patients Read More »
Starting and running a patient advocacy organization is a massive undertaking. It often includes fundraising, standing up and operating a board and non-profit structure,
BIO Coffee Chat offers advice on launching a successful patient advocacy organization Read More »
Lawmakers questioned Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. on key issues like vaccines, biosecurity, and federal research funds in a
Lawmakers question Kennedy on vaccines, biosecurity, and NIH cuts Read More »
